Resistance Training Beats WB-EMS for Metabolic Syndrome

WB-EMS promises a shortcut. The trial data do not.

Whole-body electromyostimulation, or WB-EMS, sells a simple idea: put on the suit, let the current do part of the work, and get gym-like results in about 20 minutes. That pitch lands especially well with people who have obesity, metabolic syndrome, bad knees, no time, or all four.

The problem is that the one direct randomized trial in the exact population this pitch targets did not show gym-like results where they matter most. In a 2021 randomized controlled trial by Reljic et al., 118 adults with obesity and metabolic syndrome spent 12 weeks on caloric restriction and were assigned to WB-EMS, single-set resistance training, three-set resistance training, or an inactive control. The primary endpoint was the metabolic syndrome z-score, a composite measure that rolls waist circumference, blood pressure, triglycerides, HDL cholesterol, and fasting glucose into one score. Both resistance-training groups improved that score and preserved skeletal muscle mass during dieting. WB-EMS did not outperform the inactive control on those primary outcomes.

If your goal is metabolic syndrome reversal during weight loss, the current head-to-head evidence favors iron over electricity.

That is a narrow claim, not a universal one. It does not mean WB-EMS does nothing. It means the best available trial says it did not deliver the same cardiometabolic payoff as conventional resistance training in obese adults with established metabolic syndrome.

Why this trial matters

The design makes the comparison hard to dismiss. Everyone dieted. That matters because caloric restriction alone often improves weight-related markers while also shaving off lean mass. The trial asked the practical question patients actually face: if you are already cutting calories, which training method helps your metabolic syndrome and protects muscle?

Resistance training won on both counts. Even the low-volume version, a single working set per muscle group, improved the composite metabolic syndrome score and prevented diet-related skeletal muscle loss in the 2021 trial. That is clinically useful because muscle is not decorative luggage. It is a major sink for glucose disposal and a large piece of long-term metabolic health.

The paper was powered for a moderate between-group effect, with a stated 95% power target at Cohen d = 0.63 and a minimum of 16 participants per group. That strengthens confidence that the study was built to detect a meaningful difference if one existed. It does not solve every problem, though. The evidence still rests on a single trial from one research group, and the publicly available summary does not report all the group-specific deltas, p-values, or confidence intervals needed for a more granular ranking of the interventions. The conclusion is usable; the exact size of the advantage is less certain from the published summary alone.

WB-EMS gets partial credit, but only partial

There is one important complication. In a 2022 trial from the same Erlangen-Nurnberg group, 106 patients with metabolic syndrome were randomized to low-volume HIIT, single-set resistance training, WB-EMS, three-set resistance training, or control while receiving nutritional counseling for weight loss. The paper focused on inflammatory indices rather than the metabolic syndrome z-score. Across the active exercise arms, the authors reported anti-inflammatory benefits, which suggests WB-EMS is biologically active rather than inert.

That does not overturn the 2021 result. It separates two outcomes that people often blur together. Lower inflammation is good. It is not the same thing as shifting the whole metabolic syndrome cluster in a clinically meaningful way. A device can move biomarkers without matching the broader metabolic effect of resistance training. That appears to be the story here.

The abstract of the 2022 paper also shows some marker-specific nuance. For example, it highlights reductions in C-reactive protein and interleukin-6 with low-volume HIIT, not a blanket identical response across every biomarker and every exercise arm. So the fairest reading is this: WB-EMS likely carries an anti-inflammatory signal in this population, but the evidence for full metabolic syndrome improvement remains better for resistance training.

Time-saving is not a special advantage here

The usual sales move for WB-EMS is time. Fair enough. People skip exercise because life is busy, and "busy" has defeated more training plans than physiology ever did.

But the time argument weakens once you look at what low-volume exercise can do in the same population. In a 2021 randomized trial in Scientific Reports, 117 adults with obesity and metabolic syndrome completed either very low-volume HIIT or moderate-intensity interval training, both requiring less than 30 minutes of training time per week, plus nutritional counseling. Over 12 weeks, both interval programs improved metabolic syndrome severity, body composition, fitness, and quality of life relative to control, and the very low-volume HIIT protocol was non-inferior for cardiometabolic outcomes.

A 2022 trial in the Journal of Physiology and Pharmacology pushed the same point further. Adults with obesity and metabolic syndrome completed a highly time-efficient HIIT protocol totaling 28 minutes per week for 12 weeks. The intervention improved the NAFLD fibrosis score and cardiometabolic risk indices. Different endpoint, same lesson: brief exercise can work.

Low-volume combined training also looks legitimate. In a 2025 Nutrients trial, low-volume concurrent programs that mixed resistance and cardiovascular training improved cardiometabolic health, inflammation, and fitness in obese adults with metabolic syndrome. And in a related but not identical population, a 2024 Diabetes Care trial found that two weekly sessions of low-volume HIIT plus resistance exercise improved glycemic control and cardiometabolic markers in adults with overweight or obesity and type 2 diabetes compared with routine lifestyle education.

So if the pitch is "you do not need long sessions," the evidence agrees. If the pitch is "therefore use electricity instead of exercise," the evidence does not.

What about the rest of the literature?

The wider exercise literature supports exercise for metabolic syndrome broadly. A 2023 systematic review and meta-analysis found that exercise training improved metabolic syndrome risk factors in postmenopausal women across randomized trials. A 2023 randomized trial also showed that exercise combined with a GLP-1 receptor agonist reduced metabolic syndrome severity, abdominal obesity, and inflammation more than either strategy alone after weight loss.

None of that proves resistance training is always superior to WB-EMS in every population. It does show that conventional exercise modalities repeatedly improve the outcomes clinicians and patients care about in metabolic disease, while WB-EMS has much thinner evidence and lost the one direct contest on the main endpoint.

There is also a plausible reason earlier enthusiasm for WB-EMS did not survive this test. The 2021 trial was designed in part because earlier work in healthy untrained men, cited in the paper's introduction, had suggested WB-EMS and conventional resistance training might produce similar gains in body composition, strength, and cardiometabolic risk markers. People with established metabolic syndrome are not healthy untrained men with a scheduling problem. They are a higher-risk population with worse baseline metabolic regulation. A shortcut that works tolerably well in healthy people can fail where the physiology is less forgiving.

Limits of the evidence

This is not a closed case. It is a small evidence base with one especially important trial.

• The head-to-head WB-EMS versus resistance-training result comes from one 12-week randomized trial from one research group.
• The 2022 inflammation paper may represent a separate cohort or a partly overlapping analysis; the published summaries do not fully resolve that.
• The available reports do not provide every group-level estimate and confidence interval for the 2021 primary trial, so precision is limited.
• No telomere data appear in this evidence base. Any claim that resistance training or HIIT "protects telomeres" here would be invented.
• No usable safety evidence for WB-EMS appears in these sources, so strong claims about safety or risk would also outrun the record.

Those limits should lower confidence, not erase the signal. The signal is still pretty plain.

The practical verdict

If you have obesity and metabolic syndrome and you are choosing an exercise modality to pair with calorie restriction, resistance training has the better direct evidence. In the only published head-to-head randomized trial, single-set and three-set resistance training improved the metabolic syndrome z-score and preserved muscle mass; WB-EMS did not beat inactive control on those outcomes.

WB-EMS may still have a role for people who cannot tolerate conventional training, or for narrow goals centered on adherence or inflammatory biomarkers. But replacing resistance training with WB-EMS because the suit feels futuristic is not an evidence-based move for metabolic syndrome. The barbell may be less glamorous. It is also the one with the win.